| Artificial intelligence in oncology: current applications and future perspectives C Luchini, A Pea, A Scarpa British Journal of Cancer 126 (1), 4-9, 2022 | 183 | 2022 |
| Pancreatic resections for cystic neoplasms: from the surgeon's presumption to the pathologist's reality R Salvia, G Malleo, G Marchegiani, S Pennacchio, S Paiella, M Paini, ... Surgery 152 (3), S135-S142, 2012 | 167 | 2012 |
| IPMNs with co-occurring invasive cancers: neighbours but not always relatives M Felsenstein, M Noë, DL Masica, W Hosoda, P Chianchiano, CG Fischer, ... Gut 67 (9), 1652-1662, 2018 | 142 | 2018 |
| Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: a systematic review and an exploratory meta-analysis A Nottegar, N Veronese, M Senthil, RM Roumen, B Stubbs, AH Choi, ... European Journal of Surgical Oncology (EJSO) 42 (7), 919-925, 2016 | 137 | 2016 |
| Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas A Pea, J Yu, N Rezaee, C Luchini, J He, M Dal Molin, JF Griffin, H Fedor, ... Annals of surgery 266 (1), 133-141, 2017 | 130 | 2017 |
| Genomic characterization of malignant progression in neoplastic pancreatic cysts M Noë, N Niknafs, CG Fischer, WM Hackeng, V Beleva Guthrie, ... Nature communications 11 (1), 4085, 2020 | 126 | 2020 |
| Clinical implications of the 2016 international study group on pancreatic surgery definition and grading of postoperative pancreatic fistula on 775 consecutive pancreatic … A Pulvirenti, G Marchegiani, A Pea, V Allegrini, A Esposito, L Casetti, ... Annals of surgery 268 (6), 1069-1075, 2018 | 122 | 2018 |
| Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer F Scopelliti, A Pea, R Conigliaro, G Butturini, I Frigerio, P Regi, A Giardino, ... Surgical Endoscopy 32, 4022-4028, 2018 | 120 | 2018 |
| Homologous recombination deficiency in pancreatic cancer: a systematic review and prevalence meta-analysis R Casolino, S Paiella, D Azzolina, PA Beer, V Corbo, G Lorenzoni, ... Journal of Clinical Oncology 39 (23), 2617-2631, 2021 | 117 | 2021 |
| Tumor mutational burden as a potential biomarker for immunotherapy in pancreatic cancer: systematic review and still-open questions RT Lawlor, P Mattiolo, A Mafficini, SM Hong, ML Piredda, SV Taormina, ... Cancers 13 (13), 3119, 2021 | 117 | 2021 |
| Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size WM Hackeng, LAA Brosens, JY Kim, R O'Sullivan, YN Sung, TC Liu, ... Gut 71 (5), 961-973, 2022 | 108 | 2022 |
| Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: a systematic review with meta-analysis N Veronese, A Nottegar, A Pea, M Solmi, B Stubbs, P Capelli, G Sergi, ... Annals of oncology 27 (1), 42-48, 2016 | 104 | 2016 |
| Pancreatic undifferentiated carcinoma with osteoclast‐like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma C Luchini, A Pea, G Lionheart, A Mafficini, A Nottegar, N Veronese, ... The Journal of pathology 243 (2), 148-154, 2017 | 95 | 2017 |
| Genetic analysis of small well-differentiated pancreatic neuroendocrine tumors identifies subgroups with differing risks of liver metastases A Pea, J Yu, L Marchionni, M Noe, C Luchini, A Pulvirenti, RF De Wilde, ... Annals of surgery 271 (3), 566-573, 2020 | 94 | 2020 |
| Different prognostic roles of tumor suppressor gene BAP1 in cancer: A systematic review with meta‐analysis C Luchini, N Veronese, S Yachida, L Cheng, A Nottegar, B Stubbs, ... Genes, Chromosomes and Cancer 55 (10), 741-749, 2016 | 80 | 2016 |
| Perioperative outcomes and long-term quality of life after total pancreatectomy A Pulvirenti, A Pea, N Rezaee, C Gasparini, G Malleo, MJ Weiss, ... Journal of British Surgery 106 (13), 1819-1828, 2019 | 79 | 2019 |
| Genetics of pancreatic neuroendocrine tumors: implications for the clinic A Pea, RH Hruban, LD Wood Expert review of gastroenterology & hepatology 9 (11), 1407-1419, 2015 | 75 | 2015 |
| Pancreatoduodenectomy at the Verona Pancreas Institute: the evolution of indications, surgical techniques, and outcomes: a retrospective analysis of 3000 consecutive cases C Bassi, G Marchegiani, T Giuliani, A Di Gioia, S Andrianello, ... Annals of Surgery 276 (6), 1029-1038, 2022 | 70 | 2022 |
| Multi-institutional development and external validation of a nomogram to predict recurrence after curative resection of pancreatic neuroendocrine tumors A Pulvirenti, AA Javed, L Landoni, NB Jamieson, JF Chou, M Miotto, J He, ... Annals of surgery 274 (6), 1051-1057, 2021 | 70 | 2021 |
| Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas R Salvia, S Crippa, S Partelli, G Armatura, G Malleo, M Paini, A Pea, ... World journal of gastrointestinal surgery 2 (10), 342, 2010 | 69 | 2010 |